TIME-CAP LABS, — Fluoxetine Importer Profile
Pharmaceutical Importer · #8 buyer for Fluoxetine · $2.9M import value · 83 shipments · UNITED STATES · DGFT Verified
TIME-CAP LABS, is the #8 importer of Fluoxetine from India with $2.9M in import value and 83 verified shipments. TIME-CAP LABS, holds a 1.1% market share in Fluoxetine imports based in UNITED STATES. The company sources from 1 verified supplier across 50 formulations shipped to 1 country. Overall, TIME-CAP LABS, imports 8 pharmaceutical products worth $39.1M across 5 therapeutic categories.
TIME-CAP LABS, — Fluoxetine Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Fluoxetine to TIME-CAP LABS,?
Verified from 83 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| MARKSANS PHARMA LIMITED | $2.9M | 83 | 100.0% |
TIME-CAP LABS, sources Fluoxetine from 1 verified Indian supplier based on 83 customs records. The primary supplier is MARKSANS PHARMA LIMITED accounting for 100.0% of imports.
How Does TIME-CAP LABS, Compare to Nearest Fluoxetine Importers?
Buyers ranked immediately above and below #8 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 8 | TIME-CAP LABS, ★ | UNITED STATES | $2.7M | 62 | $43.0K |
| 9 | J. KNIPPER & COMPANY | UNITED STATES | $2.6M | 117 | $21.9K |
| 10 | DR. REDDYS LABORATORIES, INC | UNITED STATES | $2.3M | 45 | $50.0K |
TIME-CAP LABS, ranks #8 among 522 Fluoxetine importers from India. Average shipment value of $43.0K compared to the market average of $41.4K. The closest competitors by value are J. KNIPPER & COMPANY and DR. REDDYS LABORATORIES, INC.
Where Does TIME-CAP LABS, Import Fluoxetine To?
Destination countries from 83 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $2.9M | 83 | 100.0% |
TIME-CAP LABS, imports Fluoxetine to 1 country. The primary destination is UNITED STATES receiving 100.0% of shipments worth $2.9M.
What Fluoxetine Formulations Does TIME-CAP LABS, Import?
| Formulation | Value | Shipments |
|---|---|---|
| PHARMACEUTICAL PRODUCTS-FLUOXETINE CAPSU | $1.1M | 28 |
| FLUOXETINE CAPSULES USP 20MG BATCH NO: 2 | $230.8K | 6 |
| PHARMACEUTICAL PRODUCTS - FLUOXETINE CAPSULES USP 40MG Batch No: 250049 | $52.5K | 2 |
| FLUOXETINE CAPSULES USP 40MG BATCH NO: 2 | $50.0K | 1 |
| PHARMACEUTICAL PRODUCTS- FLUOXETINE CAPSULES USP 40MG Batch No: 230547 | $50.0K | 1 |
| FLUOXETINE CAPSULES USP 20MG (8160 PACKx1000=8160000 CAPS)(BATCH NO.250029) | $50.0K | 1 |
| FLUOXETINE CAPSULES USP 20MG (8676 PACKX10X10X10=8676000 CAPS) BATCH NO.240097 | $50.0K | 1 |
| FLUOXETINE CAPSULES USP 20MG (8640 PACKX1000=8640000 CAPS) BATCH NO.240230 | $50.0K | 1 |
| PHARMACEUTICAL PRODUCTS - FLUOXETINE CAPSULES USP 20MG Batch No: 240291 | $50.0K | 1 |
| PHARMACEUTICAL PRODUCTS -FLUOXETINE CAPSULES USP 20MG Batch No: 240313 | $50.0K | 1 |
TIME-CAP LABS, imports 50 distinct Fluoxetine formulations from India. The top formulation is PHARMACEUTICAL PRODUCTS-FLUOXETINE CAPSU with 28 shipments worth $1.1M.
Regulatory Requirements: Importing Fluoxetine into United States
What TIME-CAP LABS, and other importers must comply with to import Fluoxetine from India
Regulatory Authority
U.S. Food and Drug Administration (FDA)
Approval Process for Generic Fluoxetine
Abbreviated New Drug Application (ANDA) for generic drugs, requiring bioequivalence studies and compliance with 21 CFR. Indian manufacturing sites must pass FDA pre-approval inspection.
Typical timeline: 10–18 months for ANDA approval
GMP Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA prior to approval
Import Licence & Documentation
Drug Listing with FDA; Import Alert screening; Customs entry via FDA PREDICT system
Labeling & Packaging
US-specific labeling per 21 CFR 201 including NDC number, lot, expiry, dosage in English
Note: Subject to FDA Import Alerts and Automatic Detention if facility has open Form 483 observations.
Regulatory information is provided for general reference based on publicly available FDA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with FDA or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Fluoxetine from India and How Much Does TIME-CAP LABS, Import?
India exported $21.6M worth of Fluoxetine through 3,702 shipments from 253 suppliers to 101 countries, serving 522 buyers globally. TIME-CAP LABS, imports $2.9M of this total, accounting for 1.1% of India's Fluoxetine exports with 83 shipments from UNITED STATES. This is verified from 83 customs shipment records covering 50 distinct formulations.
What Is the Average Order Value for TIME-CAP LABS,'s Fluoxetine Imports?
TIME-CAP LABS,'s average Fluoxetine order value is $34.5K per consignment, based on 83 shipments totaling $2.9M. TIME-CAP LABS, is based in UNITED STATES and ranks #8 among all Fluoxetine importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Fluoxetine to TIME-CAP LABS,?
TIME-CAP LABS, sources Fluoxetine from 1 verified Indian supplier: MARKSANS PHARMA LIMITED ($2.9M, 100.0%). This is based on 83 customs records.
How Does TIME-CAP LABS, Compare to Other Fluoxetine Importers?
TIME-CAP LABS, ranks #8 among 522 Fluoxetine importers from India with a 1.1% market share. The top 3 importers are TIME-CAP LABS, ($2.7M), J. KNIPPER & COMPANY ($2.6M), DR. REDDYS LABORATORIES, INC ($2.3M). TIME-CAP LABS, processed 83 shipments from UNITED STATES.
About TIME-CAP LABS,
TIME-CAP LABS, imports 8 products worth $39.1M. Beyond Fluoxetine, top products include Ibuprofen, Amino, Acetaminophen, Naproxen, Famotidine. View the complete TIME-CAP LABS, profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Fluoxetine — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Fluoxetine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: TIME-CAP LABS, matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as TIME-CAP LABS,'s capped import value divided by total capped export value for Fluoxetine across all Indian exporters.
- 5.Verified Records: This page is backed by 83 individual customs records matching TIME-CAP LABS, importing Fluoxetine, covering 50 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 101+ countries, 522+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Fluoxetine Import Data for TIME-CAP LABS,
Access order-level details, pricing data, supplier connections, and competitive analysis for TIME-CAP LABS,'s Fluoxetine imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
TIME-CAP LABS,
Full Company Profile →
8 products · $39.1M total trade · 5 categories
TIME-CAP LABS, × Fluoxetine
Verified from customs records
Company Overview
Top Products by TIME-CAP LABS,
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for TIME-CAP LABS,.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Fluoxetine. For current order-level data, contact TransData Nexus.